“Illumina’s…presentations and product descriptions revealed a workflow that infringed on the ‘607, ‘138, ‘505, and ‘487 patents, 10x Genomics and Prognosys Biosciences argued.” On October 21, 10x ...
PLEASANTON, Calif. and PARIS, Nov. 6, 2023 /PRNewswire/ -- OWKIN and 10x Genomics, Inc. (TXG), announce they have entered into an agreement to add 10x Genomics spatial omics and single-cell ...
Zacks Investment Research on MSN
10x Genomics, Cleveland Clinic team up on bladder cancer diagnostics
10x Genomics TXG recently entered into a multi-year research collaboration with the Cleveland Clinic to advance novel ...
Collaboration with Dana-Farber Cancer Institute aims to identify biomarkers linked to treatment response for the next generation of cancer therapies and to define a clinical reporting framework to ...
Collaboration will engage leading transplant clinician-scientists to study antibody-mediated rejection (AMR) and microvascular inflammation (MVI) using cellular-resolution profiling CareDx will ...
Genomics Inc. research and ratings by Barron's. View TXG revenue estimates and earnings estimates, as well as in-depth analyst breakdowns.
X Genomics (TXG) stock climbed 3.8% after revealing a Cleveland Clinic partnership for bladder cancer research using Flex ...
Debuts at AACR Annual Meeting 2026 with Data from Leading Research Institutions, Including the June Lab at the Perelman School of Medicine, University of Pennsylvania and German Cancer Research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results